DuPont de Nemours, Inc. DD reported second-quarter 2026 net income from continuing operations of $191 million or $1.37 per share, up sharply from $24 million or 17 cents per share in the year-ago quarter.
Barring one-time items, adjusted earnings came in at $1.88 per share, up from the year-ago quarter’s $1.27. The figure beat the Zacks Consensus Estimate of $1.76.
Net sales of $1,819 million increased 4% year over year and marginally topped the Zacks Consensus Estimate of $1,817.9 million. Organic sales also improved 4%, driven by continued strength across healthcare, industrial water and aerospace end markets.
DD’s Segment Highlights
Healthcare & Water Technologies generated net sales of $856 million, up 5% year over year. It missed the Zacks Consensus Estimate of $860 million. Organic sales rose 4%, while currency contributed 1%. Healthcare Technologies recorded mid-single-digit organic growth on broad-based increase led by personal protection and biopharma, while Water Technologies posted low-single-digit organic growth driven by industrial water and semiconductor markets, partly offset by weakness in the Middle East. Operating EBITDA increased 4% to $258 million.
Diversified Industrials recorded net sales of $963 million, up 3% year over year, exceeding the Zacks Consensus Estimate of $947 million. Organic sales increased 3%, supported by growth in Building Technologies from residential and non-residential construction markets and continued aerospace and electric vehicle strength in Industrial Technologies. Operating EBITDA improved 7% year over year to $213 million. READ MORE
Source: yahoo.com
Borouge International has appointed Roland Janssen as CCO, effective 1 October 2026, as the company continues to advance its integration and growth priorities. Janssen will be based at Borouge International’s headquarters in Vienna and succeeds Stefan Doboczky, who is leaving the company to pursue a new opportunity.
Inge Massen-Biemans will become Chief Sustainability Officer (CSO) effective November 1, 2026. Inge will report directly to Dimitri de Vreeze, CEO of dsm-firmenich. She succeeds Katharina Stenholm, who has decided to step down from the role at the end of 2026 to pursue other interests, after developing and executing the company’s sustainability program over the past three years.
The Hamburg site supplies products for the cosmetics and personal care industry and the Bitterfeld site produces chlorosilanes, the company said, adding that these businesses will continue, concentrated mainly at larger German sites.
